# HYDROCHLOROTHIAZIDE; IRBESARTAN
> **ANDA201616** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LIMITED · Approved 2012-09-28
## Drug
- **FDA Application Number:** ANDA201616
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCHLOROTHIAZIDE; IRBESARTAN
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; IRBESARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2012-09-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201616)
---
*AI Analytics · CC0 1.0*